CLASS ACTION UPDATE for NSANY, CURO and DXC: Levi &

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
34
CLASS ACTION UPDATE for NSANY, CURO and DXC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

Nissan Motor Co., Ltd. (OTCMKTS: NSANY) Class Period: December 10, 2013 - November 16, 2018 Lead Plaintiff Deadline: February 8, 2019 Join the action: https://www.zlk.com/pslra-1/nissan-motor-co-l...orm?wire=3

Allegations: Nissan Motor Co., Ltd. made materially false and/or misleading statements and/or failed to disclose that: (1) for more than a decade, Nissan had been materially understating its costs--and thus overstating profits--by paying a material portion of Ghosn’s executive compensation in the form of billions of Yen of deferred compensation that the Company was concealing from its public financial reports; (2) in so doing, Nissan was concealing from investors significant defects in its corporate governance; (3) Nissan’s overpayment of defendant Ghosn had caused it to exceed its shareholder-approved executive pay cap, thus threatening its continued stock listing; (4) Nissan lacked effective internal and reporting controls; and (5) as a result, defendants’ statements about Nissan’s business metrics, operations, and financial prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

To learn more about the Nissan Motor Co., Ltd. class action contact jlevi@levikorsinsky.com .

CURO Group Holdings Corp. (NYSE: CURO) Class Period: July 31, 2018 - October 24, 2018 Lead Plaintiff Deadline: February 4, 2019 Join the action: https://www.zlk.com/pslra-1/curo-group-holdin...orm?wire=3

The complaint alleges that throughout the class period Defendants materially misrepresented to investors the deleterious effect that the up-front loan loss provisioning in connection with a transition of its Canadian inventory to Open-Ended loans was having on the Company’s financial performance and 2018 full-year Company guidance. Because CURO’s Open-End Loans had a materially lower lending yield than the Single-Pay Products, and the portfolio of Open-End Loans was still immature and unseasoned, the up-front loan loss provisioning for these loans was far greater than publicly revealed (and the yield far lower). This caused the Company to materially overstate its 2018 projected financial results, including CURO’s adjusted EBITDA, net revenue and operating earnings.

To learn more about the CURO Group Holdings Corp. class action contact jlevi@levikorsinsky.com .

DXC Technology Company (NYSE: DXC) Class Period: February 8, 2018 - November 6, 2018 Lead Plaintiff Deadline: February 25, 2019 Join the action: https://www.zlk.com/pslra-1/dxc-technology-co...orm?wire=3

Allegations: During the class period, DXC Technology Company made materially false and/or misleading statements and/or failed to disclose that: (a) the Company had changed or planned to change the operations of its sales teams, deploying generalized sales teams as opposed to the specialized teams that were better capable of delivering specialized services to its clients; (b) the Company’s workforce optimization strategy of sharply reducing staff while reducing costs was resulting in a shortage of sales personnel who could execute on demand for services, thereby risking and ultimately losing sales and revenue opportunities; (c) in light of the above, the Company’s revenue and financial performance guidance for the fiscal year 2019 and its reaffirmation of the guidance during the Class Period was without a reasonable basis.

To learn more about the DXC Technology Company class action contact jlevi@levikorsinsky.com .

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 55 Broadway, 10th Floor New York, NY 10006 jlevi@levikorsinsky.com Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Explore the 2025 Best Online Programs by U.S. News Today

Updated Category News Views 363

Introduction to Online Education Rankings Education plays a vital role in shaping careers and personal development. Recognizing this, U.S. News & World Report has unveiled its rankings for the 2025 Best Online Programs. This initiative aims to assist students who are seeking flexible learning opportunities that fit their lifestyle. With nearly 1,800 online programs...

Continue Reading
Tetsuya Bessho Celebrates New Achievements in Short Film Festival

Updated Category News Views 132

Tetsuya Bessho Announces Key Awards for Film Festival Actor Tetsuya Bessho, who serves as the president of the Academy Award qualifying Short Shorts Film Festival & Asia (SSFF & ASIA), recently held a significant meeting with the Governor of Tokyo. During this productive courtesy call, Bessho announced the prestigious Best Short Award for the Cinematic Tokyo Competition,...

Continue Reading
Avenue Therapeutics Showcases Insights at Healthcare Summit

Updated Category News Views 47

Avenue Therapeutics Set to Shine at Upcoming Healthcare Summit MIAMI, Oct. 09, 2024 — Avenue Therapeutics, Inc. (Nasdaq: ATXI), a dedicated specialty pharmaceutical company, is gearing up for an impactful presence at the upcoming Maxim Group’s 2024 Healthcare Virtual Summit. On this important occasion, Alexandra MacLean, M.D., the Chief Executive Officer of Avenue...

Continue Reading
Marine Battery Industry Projected to Hit $1.5 Billion by 2030

Updated Category News Views 103

Significant Growth in the Marine Battery Market The marine battery market is undergoing remarkable growth, estimated at USD 882.3 million in 2024 and projected to reach USD 1,506.0 million by 2030. This represents a robust compound annual growth rate (CAGR) of 9.3% from 2024 to 2030. Manufacturers in this sector are increasingly focused on delivering efficient, durable,...

Continue Reading
Investors: Act Now to Recover Losses from Methode Electronics

Updated Category News Views 99

Investors Encouraged to Act on Methode Electronics Lawsuits Kahn Swick & Foti, LLC, a respected name in securities litigation, is reminding investors about impending deadlines related to class action lawsuits against Methode Electronics, Inc. (NYSE: MEI). If you suffered financial losses exceeding $100,000 during the specified Class Period, it is crucial to be informed of...

Continue Reading